NKE vs VERA · P/E 35, rev $46.40B vs $2.51B cap
Nike Inc (NKE) versus Vera Therapeutics Inc (VERA) — a side-by-side from cached financials, not a winner call.
Nike Inc (NKE) is a footwear & accessories company listed on US. It is led by John Donahoe.
Vera Therapeutics Inc (VERA) is a biotechnology company listed on NASDAQ.
Latest reported NKE revenue for 2026-05-31 was $46.40B. Net income was $3.11B. Revenue was up 0.2% from 2025-05-31 to 2026-05-31. NKE currently screens at market cap $110.14B and trailing P/E 34.6.
VERA does not have a complete income-statement cache yet.
NKE currently screens at market cap $110.14B and trailing P/E 34.6. VERA currently screens at market cap $2.51B.
Not investment advice. Open the NKE and VERA stock pages for the full models.
Not investment advice.